Evidence map›Paper›PMID 32443795›Full record

ArticlePolymers2020

Collagen Scaffolds Containing Hydroxyapatite-CaO Fiber Fragments for Bone Tissue Engineering.

Shiao-Wen Tsai, Sheng-Siang Huang, Wen-Xin Yu, Yu-Wei Hsu, Fu-Yin Hsu

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shiao-Wen TsaiGraduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan City 333323, Taiwan.ORCID 0000-0002-6225-6613
Sheng-Siang HuangDepartment of Bioscience and Biotechnology, National Taiwan Ocean University; Keelung City 202301, Taiwan.
Wen-Xin YuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University; Keelung City 202301, Taiwan.
Yu-Wei HsuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University; Keelung City 202301, Taiwan.
Fu-Yin HsuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University; Keelung City 202301, Taiwan.ORCID 0000-0002-8221-4218
National Taiwan Ocean University · TWChang Gung University · TW

Funding

Ministry of Science and Technology of Taiwan MOST 105-2221-E-019-008, MOST 106-2221-E-019 -021 -MY2 and MOST 108-2221-E-019 -029 -MY2.
6 · The paper itself

Abstract

Collagen (COL) and hydroxyapatite (HAp) are the major components of bone, therefore, COL-HAp composites have been widely used as bone substitutes to promote bone regeneration. We have reported that HAp-CaO fibers (HANFs), which were fabricated by a sol-gel route followed by an electrospinning technique, possessed good drug-loading efficiency and limited the burst release of tetracycline. In the present study, we used HANF fragments to evaluate the effects of COL-HANF scaffolds on MG63 osteoblast-like cell behaviors. COL-HANF composite scaffolds in which the average diameter of HANFs was approximately 461 ± 186 nm were fabricated by a freeze-drying process. The alkaline phosphatase activity and the protein expression levels of OCN and BSP showed that compared with COL alone, the COL-HANF scaffold promoted the differentiation of MG63 osteoblast-like cells. In addition, the bone regeneration ability of the COL-HANF scaffold was examined by using a rabbit condylar defect model in vivo. The COL-HANF scaffold was biodegradable and promoted bone regeneration eight weeks after the operation. Hence, we concluded that the COL-HANF scaffold has potential as a bone graft for bone tissue engineering.

Indexed as

bone regenerationcollagencompositefiber fragmentshydroxyapatitescaffold

Identifiers

PMID32443795
PMCPMC7284761
OpenAlexW3028125493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.